Clinical Trial Update: Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC) [Phase 3]

View source ↗

Summary

Phase III trial comparing treosulfan-based conditioning to reduced-intensity conditioning in acute myeloid leukemia and myelodysplastic syndrome; trial complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• treosulfan-based conditioning

Snippet

Sponsor: medac GmbH | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 3 | Status: COMPLETED